Compare GALT & KINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GALT | KINS |
|---|---|---|
| Founded | 2000 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.7M | 209.0M |
| IPO Year | 2008 | 2013 |
| Metric | GALT | KINS |
|---|---|---|
| Price | $3.10 | $15.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 311.9K | 86.5K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | ★ 1.32% |
| EPS Growth | N/A | ★ 359.65 |
| EPS | N/A | ★ 1.82 |
| Revenue | N/A | ★ $155,142,103.00 |
| Revenue This Year | N/A | $10.53 |
| Revenue Next Year | N/A | $15.00 |
| P/E Ratio | ★ N/A | $8.30 |
| Revenue Growth | N/A | ★ 7.60 |
| 52 Week Low | $1.15 | $13.08 |
| 52 Week High | $7.13 | $22.20 |
| Indicator | GALT | KINS |
|---|---|---|
| Relative Strength Index (RSI) | 49.40 | 40.86 |
| Support Level | $2.88 | $14.38 |
| Resistance Level | $3.27 | $15.51 |
| Average True Range (ATR) | 0.24 | 0.55 |
| MACD | 0.03 | -0.14 |
| Stochastic Oscillator | 37.71 | 31.00 |
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Kingstone Companies Inc is a multi-line regional property and casualty insurance holding company. It offers insurance policies to small and mid-sized businesses as well as to individuals.